| Dr James T Higgins, MD | |
|
72 Highland Ave, Pediatric Associates Of Greater Salem, Salem, MA 01970-2738 | |
| (978) 745-3050 | |
| (978) 744-9594 |
| Full Name | Dr James T Higgins |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 72 Highland Ave, Salem, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598737520 | NPI | - | NPPES |
| 2049309 | Medicaid | MA | |
| D28147 | Other | BS | |
| 038746 | Other | TUFTS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 38746 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr James T Higgins, MD 72 Highland Ave, Pediatric Associates Of Greater Salem, Salem, MA 01970-2738 Ph: (978) 745-3050 | Dr James T Higgins, MD 72 Highland Ave, Pediatric Associates Of Greater Salem, Salem, MA 01970-2738 Ph: (978) 745-3050 |
News Archive
Provectus Biopharmaceuticals, Inc. (PVCT), a development-stage oncology and dermatology biopharmaceutical company, today announced that it has received the official minutes from the Type C meeting held with the FDA's Division of Oncology Products 2 on December 16, 2013.
Investigators with The Cancer Genome Atlas (TCGA) Research Network have identified new potential therapeutic targets for a major form of bladder cancer, including important genes and pathways that are disrupted in the disease.
Researchers report the discovery that a protein called "Runx3" programs killer T cells to establish residence in tumors and infection sites.
The American College of Occupational and Environmental Medicine (ACOEM) has released the Third Edition of Occupational Medicine Practice Guidelines to subscribers of the guideline development and content publishing platform, APG-I. The proprietary, evidence-based system provides full access to ACOEM's complete guidelines, featuring thousands of pages of the most current evidence medical treatment recommendations.
Researchers have identified the cells that likely give rise to the brain tumor subtype Group 4 medulloblastoma. The finding removes a barrier to developing more effective targeted therapies against the brain tumor's most common subtype.
› Verified 5 days ago
Linda J Morgan, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 57 Highlands Ave, Er, Salem, MA 01970 Phone: 978-354-2815 Fax: 978-744-9247 | |
Jean L Sheeley, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 72 Highland Ave, Salem, MA 01970 Phone: 978-745-3050 Fax: 978-744-9594 | |
Dr. Donald T Mcauliffe, MD Pediatrics Medicare: May Accept Medicare Assignments Practice Location: 72 Highland Avenue, Pediatric Associates Of Greater Salem, Salem, MA 01970 Phone: 978-445-3050 Fax: 978-744-9594 | |
Dr. Cheryl M D Souza, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 72 Highland Ave, Pediatric Associates Of Greater Salem, Salem, MA 01970 Phone: 978-745-3050 Fax: 978-744-9594 | |
Dr. Donna Khodarahmi Wren, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 81 Highland Ave, North Shore Medical Center, Salem, MA 01970 Phone: 978-354-2815 Fax: 978-740-4702 | |
Dr. Jocelyn Sicat, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 72 Highland Ave, Salem, MA 01970 Phone: 978-745-3050 | |
Andrea P Tish, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 57 Highland Ave, Er, Salem, MA 01970 Phone: 978-354-2815 Fax: 978-744-9247 |